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disease,
The present study examined the recent report
that transplantation of neonatal striatal tissue
into kainic acid (KA) lesioned striatum protected
the contralateral striatum from a subsequent KA
lesion.We did not find a significant difference in
the survival rate of animals that received
neonatal striatal transplants into a KA lesioned
striatum followed by a subsequent lesion of the
contralateral striatum compared to those
animals that received bilateral KA-induced
striatal lesions alone. The tissue transplants did
not protect against the degeneration of striatal
neurons induced by KA. Indeed, the survival
rate was very low (25%) in the transplant groups.
A second experiment was also performed to
examine whether a neonatal striatal transplant
might reduce the severe syndrome of aphagia
and adipsia associated with KA lesions of the
striatum. Animals that received the neonatal
striatal transplants showed increased aphagia
and adipsia compared to animals only receiving
theKA lesion. Again, the transplant group had a
very low survival rate (10%). The present study
was unable to confirm that neonatal striatal
transplants protect against KA lesions either by
themselves or in conjunction with a recent KA
lesion.
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Neural tissue transplants represent a
potential approach to treating brain injury and
neurodegenerative disorders in humans. They
have been shown to reverse the behavioral
deficits observed in several animal models of
neurodegenerative diseases /4,8,10/. Earlier
research has utilized kainic acid (KA) injections
into the striatum of adult rats to create a model
with many of the anatomical and behavioral
abnormalities seen in patients with Huntington’s
disease (HD) /13,14/. In adult rats, KA is an
excitotoxin which selectively destroys neuronal
perikarya, while leaving axons and terminals
intact /13/. It has been postulated that an
endogenous excitotoxin with some properties
similar to KA may be responsible for the
neurodegeneration associated with HD/1,15L In
order for neural transplantation to become
clinically useful, it must be determined whether
the transplanted tissue will be affected by the
underlying neurodegenerative process.
Recently, Tullipan et al. /16,17/ suggested that
neonatal striatal transplants would protect
against lesions by the excitotoxins, KA and
quinolinie acid. Neonatal grafts were used
because of their apparent resistance to KA
toxicity both in vivo and in vitro/3,7,18,19/. They
postulated that there was a neurohumoral
influence provided either by the grafted tissue,
the lesioned striatum, or by an interaction
between the graft and the lesioned host tissue
which served to protect against excitotoxie
lesions. Because of the potential clinical
importance, the present study attempted to
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replicate this finding, and test whether the
transplant functions alone or in conjunction with
the lesioned striatum.
Two separate experimental protocols were
utilized in these studies. The design of the first
experiment was based upon the work of Tullipan
et al./16/. Male Sprague-Dawley rats weighing
240-300 g were divided into 4 groups: 1) bilateral
striatal KA lesioned, each lesion separated by 3
days (n=8); 2) KA lesion of one striatum
followed 3 days later by neonatal striatal
transplant of the ipsilateral striatum and KA
lesion of the contralateral striatum (n=8); 3) KA
lesion of one striatum followed 3 days later by
neonatal cortex transplant into the ipsilateral
striatum and KA lesion of the contralateral
striatum (n=8); 4) sham lesion followed 3 days
later by sham transplant of the ipsilateral
stratum and sham lesion of the contralateral
striatum (n=8). All rats were anesthetized with
chloral hydrate (400 mg/kg, i.p.) and then
stereotaxically positioned. AllKA lesions used 10
nmol KA in 2 ul of phosphate buffered saline
(PBS) (pH=7.4). The KA was injected over a
two minute period and the needle was left in
place an additional 2 minutes. The KA was
injected into the striatum of the adult rat using
the following coordinates: 1.5 mm AP, 2.6 mm
ML relative to bregma and 4.8 mm DV from
dura /11/. All transplanted striatal tissue was
obtained from 1-4 day neonatal rat pups. The rat
pups were decapitated, the skin and calvarium
removed and the whole striatum dissected.
Whole sections of neonatal striatum were
aspirated into a glass capillary tube affixed to a
hamilton syringe. The solid neonatal graft (2-4
ul) was then implanted into the striatum of the
adult rat using the same coordinates as above/2/.
The tissue was injected over two minutes with
the needle remaining in place for an additional 2
minutes. The tissue preparation and transplant
operation was performed under sterile
conditions. The time from dissection until
transplantation was less than 15 minutes in all
a.nimals. All animals received 4 ml of 5%
dextrose on the day of surgery and for the
following 3 days, in addition to standard rat chow
and water. Animals were weighed daffy for two
weeks following the surgery.
Gross histological examination was
performed on the surviving animals from the
above experiment. The rats were anesthetized
and then perfused with normal saline for 5
minutes followed by a 10% formalin solution.
The brains were removed and stored in 20%
sucrose in 0.9M phosphate buffer. The fixed
brains were prepared for sectioning by freezing
with CO2 and a Leitz microtome was used to
obtain 20 micron coronal sections. The slides
were prepared for staining with cresyl violet/llL.
Animals from the first study which attempted
to replicate the work of Tullipan et al./16/had
an extremely high mortality rate. By one week,
postoperative, only 1 of 8 animals (group 1)
receiving the bilateral KA lesion and no
transplant had survived. Similarly, groups of 8
animals receiving either the striatal (group 2) or
cortex (group 3) transplants had only 2 of 8
survivors per group at 1 week post-operatively.
The control group had 7 of 8 animals survive.
There was no significant difference in mortality
rate between the transplanted animals and the
bilaterally lesioned animals. As shown in Table 1,
the control animals that received sham lesions
and a sham transplant had a significantly lower
mortality rate than either the transplanted
animals (z=2.52, p<0.005) or the bilaterally
lesioned animals (z=3.01, p<0.001; test for
significance of proportions).
There was a bilateral shrinkage of the striatal
parenchyma and an enlargement of the lateral
ventricles apparent in both the animals that
received bilateral KA lesions and the animals
that received the KA striatal lesion followed by
an ipsilateral neonatal striatal transplant and a
contralateral striatal KA lesion (see Figure 1).
The extent of the KA-induced lesions of the
striatum were similar regardless of whether the
animal received a neonatal striatal transplant.
Also, consistent with the findings of previous
studies/16/, there was little evidence for survival
of the neonatal graft. In some cases, however,
the graft could be seen as depicted in Fig. 1.
In the second experiment a variation of
Tullipan et al.’s /16/ experimental protocol was
used. Male Sprague-Dawley rats weighing 210-
240 g were divided into an experimental group
(n=10) and a control group (n=9). Animals
were anesthetized and positioned in the
stereotaxic frame as in the previous experiment.
In the experimental group, animals received a
neonatal striatal transplant into an unlesioned
striatum using the same coordinates and
procedures as in the previous experiment.
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TABLE 1. The effect of neonatal striatal transplants on the
mortality of animals receiving kainic acid lesions*
Experiment
Group Survival Rate
Bilateral Lesion 1/8
Lesion/Striatal Trans.-Lesion 2/8
Lesion/Cortical Trans.-l_msion 2/8
Sham Lesion/Sham Trans.-
Sham Lesion 7/8
Experiment II
Striatal Trans. & Lesion
Sham Trans. & Lesion
1/10
5/9
* In experiment I animals were divided into 4 groups: 1)
bilateral striatal lesion, each lesion separated by 3 days; 2)
KA lesion of one striatum followed 3 days later by
ipsilateral neonatal striatal transplant and KA lesion of the
contralateral striatum; 3) same as. group 2 except cortex
transplants were substituted for striatal, and 4) sham lesion
of one striatum followed 3 days later by an ipsilateral sham
transplant and sham lesion of the contralateral striatum.
Animals that received transplants had no significant
difference in mortality from those animals that received
bilateral striatal KA lesions. Animals in the sham group
that received sham lesions and a sham transplant had a
significantly lower mortality rate than either the bilateral
lesion group (z=3.01, p<0.001) or the transplant groups
(z=2.56, p<0.005; test for significance of proportions). In
Experiment II rats in the experimental group received a
transplant of neonatal striatal tissue into one striatum and
simultaneously received a 10 nmole KA lesion in the
eontralateral striatum. Animals in the control group
received a sham transplant with lactated Ringers solution
and a KA lesion of the contralateral striatum. Animals that
received striatal transplants had a significantly increased
mortality compared to the control group (z=2.12, p<0.02;
test for significance of difference between two proportions).
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Immediately following the transplant these
animals received an injection of KA (10 nmol)
into the contralateral striatum. The control
group received a sham transplant with lactated
ringers (2-4 ul) in place of the neonatal tissue.
Immediately following the sham transplant these
animals received an injection of KA (10 nmol)
into the contralateral striatum. All animals in this
experiment received the same post-operative
treatment as in the first experiment.
In the second experiment all animals in both
groups demonstrated both barrel rotations and
seizure activity in the immediate post-operative
Fig. 1: CO Photomicrograph of coronal section of a
representative rat brain which received
bilateral Onmole KA lesions of the strlatum
(St) 3 days apart. (B) Photomicrograph shows
an animal that received a KA lesion of the left
striatum followed 3 days later by a neonatal
striatal transplant and lesion of the
contralateral striatum. Note the similar extent
of the K/k-induced damage in the two brains,
as evidenced grossly by the dilation o1’ the
ventricles (V) and shrinkage of the striatum
(St). Arrow points to the neonatal transplant.
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period suggesting a successful unilateral lesion.
In the experimental group (neonatal striatal
transplant into one striatum followed
immediately by a KA lesion of the contralateral
striatum) 6 animals died within the first week of
the surgery apparently due to the syndrome of
aphagia and adipsia. The average pre-operative
weight was 216 g in the experimental group and
by day 4 the average weight had fallen to 176 g.
This represented a 19% fall in body weight. By
the end of the second week nine out of ten of the
rats which had received striatal transplants had
died. In the control group (sham transplant into
one striatum followed immediately by a KA
lesion of the contralateral striatum) 3 animals
died within the first week of surgery. In this
group, however, the syndrome of aphagia and
adipsia was much less severe. Animals had an
average pre-op weight of 234 g. The rats reached
a nadir for weight on day 3 down to 207 g (Figure
2). This represented only a 12% loss in weight.
By the end of the second week only 4 out of 9 of
control animals that had received a sham
transplant had died. Therefore, animals that
received the striatal transplant had a significantly
higher mortality compared to animals that
received the sham transplant (z=2.12, p<0.02
test of significance of proportions) see Figure 2.
In the present study we demonstrated that the
transplants either alone or in conjunction with a
lesioned striatum failed to protect against the
lethal effects of KA injected into the stfiatum,
the syndrome of aphagia and adipsia, and the
histological changes also associated with KA
lesions of the striatum. We found that the
experimental protocol reported by Tullipan et al
/16/ produced death in virtually all animals
regardless of whether they received a neonatal
striatal transplant. Possibly the extremely toxic
effect of the large dose of KA masked whatever
protective effect may have been present.
Additionally, the mortality rate was further
increased by the stress of two surgical
procedures, thereby confounding the probability
of demonstrating any protective effect. Although
our findings are convincing, a number of notable
differences exist between our study and that of
Tullipan et al/16/. First a difference in rat sex,
strain and weight may explain the increase in
mortality from KA lesions in our experiments
/12/. While we used male Sprague-Dawley rats
weighing between 240-300 g, Tullipan’s group
used female Lewis rats weighing between 175-
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Fig. 2: Effect of transplants on KA-induced body
weight loss. Animals from Experiment II were
weighed daily to determine if the transplant
protects from the KA-induced syndrome of
aphagla and adipsla. Animals that received
transplants actually lost more weight and took
longer to recover than animals that received
sham transplants instead of stdatal
transplants.
200 g. KA dose and donor age were comparable.
A second factor could be a difference in the
neurotoxicity of two separate batches of KA.
Furthermore, in attempting to duplicate this
work our rats received no special post-operative
care other than 4 ml of5% dextrose for 3 days. If
the animals in previous studies received some
post-op care, e.g. tube feedings or food mash
preparations, then this may have also influenced
animal survival.
In our second experiment we showed that
transplants actually increased mortality in
experiments where animals received only the
neonatal striatal transplants and simultaneous
contralateral lesions with KA. In this case the
transplants themselves could have damaged one
striatum while the KA damaged the other
striatum and, thereby, contributed to the
increase in mortality/6/. Furthermore, animals
which received striatal transplants showed a
more profound syndrome of aphagia and adipsia
suggesting these animals sustained more striatal
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damage than those animals that only received
sham transplants.
The histological evidence from the first
experiment also served to demonstrate that the
transplants failed to protect against KA lesions.
The animals that received striatal transplants
had no protection in terms of size of the KA-
induced lesions. Interestingly, as in previous
studies/16/, there was no evidence of the solid
neonatal striatal graft.
Recently, Levivier et al/9/found that fetal
stdatal transplants could protect against the
apomorphine-induced turning behavior that
results from unilateral quinolinic acid lesions of
the pre-transplanted striatum. However,
histological analysis of their animals did not
reveal any protection in terms of the size of the
lesion, similar to the present results. It is possible
that the protection of the behavioral deficits seen
by Levivier et al /9/ may be due to some
protective factor as reported by Tullipan et al
/16/. However, apomorphine-induced rotation
can be affected by a number of different
variables and can even be reduced by larger
striatal lesions, per se /5L Therefore, further
work should be done with other behavioral
paradigms to clarify this issue.
The present study strongly suggests that there
is no protective effect of neonatal transplants at
high doses of KA. Because of the potential
clinical significance of this area, it would be
interesting to look for possible protective effects
of transplants on the behavioral and
morphological effects of lower doses of
excitotoxins.
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